Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 28:9:579-86.
doi: 10.2147/OTT.S95658. eCollection 2016.

Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis

Affiliations

Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis

Nannan Liu et al. Onco Targets Ther. .

Abstract

The relationship between XRCC1 polymorphisms and bladder cancer has been widely studied. Here, our meta-analysis was conducted to evaluate the correlations between common genetic polymorphisms in XRCC1 and susceptibility to bladder cancer. In order to derive a more precise estimation of the association, 27 clinical case-control studies (which met all the inclusion criteria) were included in this meta-analysis. A total of 8,539 cancer cases and 10,750 controls were involved in this meta-analysis. Overall, no significant association was detected in allelic model (A allele vs T allele odds ratio [OR] =0.87, 95% confidence interval [CI], 0.71-1.06), homozygote comparison (AA vs GG OR =1.12, 95% CI, 0.68-1.85), heterozygote comparison (AT vs TT OR =1.01, 95% CI, 0.81-1.26), dominant model (AA + AG vs GG OR =0.93, 95% CI, 0.85-1.02), and recessive model (AA vs AG + GG OR =1.01, 95% CI, 0.88-1.15), but a moderately significant association was found for AG vs GG (OR =0.241, 95% CI =0.17-0.35). Subgroup analysis based on ethnicity. Ethnicity analysis suggested that genetic polymorphisms in XRCC1 were not correlated with increased bladder cancer risk among Asians (all P>0.05). Therefore, we concluded that XRCC1 genetic polymorphism may not contribute to bladder cancer susceptibility in the present meta-analysis, and further well-designed studies with a large sample size are warranted to validate our conclusion.

Keywords: XRCC1; bladder cancer; genetic polymorphism; meta-analysis; susceptibility.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Odds ratios for associations between single nucleotide polymorphism Arg399Gln in XRCC1 and bladder cancer risk. Notes: (A) A allele vs G allele; (B) AA vs GG; (C) AA + AG vs GG; (D) AA vs AG + GG. Weights are from random effects analysis. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 1
Figure 1
Odds ratios for associations between single nucleotide polymorphism Arg399Gln in XRCC1 and bladder cancer risk. Notes: (A) A allele vs G allele; (B) AA vs GG; (C) AA + AG vs GG; (D) AA vs AG + GG. Weights are from random effects analysis. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 2
Figure 2
Forest plot of XRCC1 Arg399Gln AG genotypes versus the GG genotype. Note: Weights are from random effects analysis. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 3
Figure 3
Funnel plot of two single nucleotide polymorphisms Arg399Gln in XRCC1 and bladder cancer risk. Note: Begg’s funnel plot with pseudo 95% confidence limits. Abbreviations: OR, odds ratio; SE, standard error.

Similar articles

Cited by

References

    1. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol. 2007;25(3):285–295. - PubMed
    1. Kogevinas M, ‘t Mannetje A, Cordier S, et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control. 2003;14(10):907–914. - PubMed
    1. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89(3):630–639. - PubMed
    1. Helzlsouer KJ, Harris EL, Parshad R, Perry HR, Price FM, Sanford KK. DNA repair proficiency: potential susceptibility factor for breast cancer. J Natl Cancer Inst. 1996;88(11):754–755. - PubMed
    1. Wei Q, Spitz MR. The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev. 1997;16(3–4):295–307. - PubMed

LinkOut - more resources